Pain clinics and physiotherapists have been using large, complex pieces of equipment with cables to relieve back or joint pain but a company says they have developed a breakthrough in anti-pain treatments. They claim people suffering from headaches will soon be able to use this technique to treat them at home rather than depend on drugs with numerous side-effects.

The technique is called CEFALY(R) and was demonstrated for the first time at the international medical fair MEDICA in Düsseldorf last November. A polish company (Medic-Mar http://www.medicmar.com.pl) has made Poland the first country where Cefaly is available for patients suffering from headaches.

They say their technological breakthrough is two-fold, involving miniaturization and perfect precision.

The pharmaceutical industry is currently facing some key challenges, like an increase in drug development costs, a decrease in the number of drugs being approved and scrutiny from regulatory authorities. Patients themselves are also demanding more effective and safer drugs.

Pharmacogenomics says they can help to guide drug development and therapy by correlating gene expression with a drug's efficacy.

DUBAI, United Arab Emirates, January 14 /PRNewswire/ -- Mr. Abdul Rahman Al Saleh, the senior Executive Director of Corporate Affairs at Dubai Customs has revealed that he foiled a number of attempts last year to smuggle banned rare animals into the country.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090114/334645)

This was announced at the press conference held on Wednesday 14th January 2009 at Dubai Customs main building. Mr. Yousif Al Sahlawi, Executive Director of Customs Policies and Legislations and Mr. Mohammed Al Marri, Executive Director of Customs Cargo Operations took part, in the presence of a number of media representatives and Arab and International news agencies' correspondents.

EAST GREENBUSH, New York, January 14 /PRNewswire/ --

- Leading Professional Services Software in US now available for Small and Start-up IT Resellers in the United Kingdom

Following a successful test market of its software in the United Kingdom during the Summer and Fall months of 2008, Autotask Corporation today announced that its popular and affordable IT services management tool, Autotask Go!(R), is now broadly available to IT resellers doing business in the United Kingdom through a self-service, e-commerce web site.

CAMBRIDGE, England, January 14 /PRNewswire/ --

- Orthomimetics Limited, the UK-Based Regenerative Medicine Company, has Received CE Mark Approval for Chondromimetic, its Flagship Product for the Repair of Articular Cartilage and Bone

This approval enables the company to market its line of bioresorbable implants for bone and/or soft tissue repair in the EU. Orthomimetics' family of products was developed during a groundbreaking collaboration between the University of Cambridge and the Massachusetts Institute of Technology.

SPARKS, Maryland, January 14 /PRNewswire/ --

- Can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections

BD Diagnostics, a segment of BD, today announced the worldwide launch of the BD BACTEC(TM) FX Blood Culture System to detect bloodstream infections. This new system improves clinical decision-making and laboratory workflow by markedly improving blood culturing practices with real-time, remotely accessible, actionable results that can enhance patient care. The BD BACTEC FX System is designed to continue the media performance excellence expected from the BD BACTEC line: from Plus and Lytic to Peds and media for yeast, fungi or mycobacteria recovery.

CHICAGO, January 14 /PRNewswire/ --

- Enhanced multi-broker functionality and faster access to multiple dark pools streamline trader workflow

Townsend Analytics (http://www.townsendanalytics.com), the leading provider of global multi-broker, cross-asset electronic trading solutions, has released the latest version of its RealTick Execution Management System (EMS). The release includes expanded multi-broker functionality, enhanced list trading capabilities and the ability to route orders to multiple dark pools, broker algorithms or liquidity venues in one click.

Many improvements answer global client demand for personalized features and functions, including:

-- Customizable order forms for specific trading styles and strategies, including list trading

KRAKOW, Poland, January 14 /PRNewswire/ --

- Comarch's Offering for Telecoms Receives a Strong Rating in Leading Analyst's BSS Market Overview and Strategic Scorecard for Vendors (2008)

Today, Comarch announced that it has been rated as strong in Gartner's Business Support System Market Overview and Strategic Scorecard for Vendors, 2008 report, and as stable in the OSS Market Overview and Strategic Scorecard for Vendors, 2008 report.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090114/334685)

LONDON, January 14 /PRNewswire/ --

- .tel Domains Reach Fans in Parts of the World Which Other Internet Sites Struggle With

Telnic Limited (http://www.telnic.org), the registry operator for the new .tel top level domain (TLD), today announced that internationally-recognized football clubs were in danger of missing out in securing their .tel domain names and a strong communications and revenue-generating channel to their millions of fans worldwide.

OSLO, Norway, January 14 /PRNewswire/ --

- Results Highlight the Potential of Alpharadin to Treat Bone Metastases in Major Cancer Indications

OSLO, Norway, January 14 /PRNewswire/ --

Algeta ASA (OSE: ALGETA), the cancer therapeutics company, announces that with the results of the BC1-04 study reported today it has completed its comprehensive phase II clinical program evaluating Alpharadin (radium-223) as a new treatment for bone metastases in patients with hormone-refractory prostate cancer (HRPC). The program provides strong evidence that Alpharadin can prolong patient survival times, improve quality of life and offer a placebo-like safety profile.